Company intelligence / Profile preview

NoviSystems

Raleigh, North Carolina, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Other

Overview

Fusion Analytics has been validated in collaboration with Thermo Fisher Scientific at 16 global drug-manufacturing sites. The platform enables improved operational performance, deviation/process/release analytics, and supports rare disease diagnosis/treatment through advanced data integration and visualization tools.

Therapeutic areas: Rare Diseases
Modalities: Not directly developing therapeutics; provides analytics solutions for modalities including cell/gene therapy, individualized medicine, and rare disease management
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Thermo Fisher Scientific Corp. – collaboration on validation/deployment of Fusion Analytics at 16 manufacturing sites worldwideAdvisory team focused on rare diseases assembled from industry experts

Beyond the preview

Go deeper on NoviSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NoviSystems.

Explore the full profile